Christopher Yea

Companies

• KalVista Pharmaceuticals, Inc.Chief Development Officer Nov 29, 2016 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KPKalVista Pharmaceuticals, Inc.0 shares²Jun 11, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 11, 2026Returned to company 229,918 shares of KalVista Pharmaceuticals, Inc.²
• May 27, 2026Sold 33,800 shares at $26.78 of KalVista Pharmaceuticals, Inc.³
• May 27, 2026Exercised options 33,800 shares at $7.07 of KalVista Pharmaceuticals, Inc.³
• May 26, 2026Sold 1,966 shares at $26.78 of KalVista Pharmaceuticals, Inc.⁴
• May 22, 2026Sold 2,358 shares at $26.78 of KalVista Pharmaceuticals, Inc.⁵
• May 22, 2026Exercised options 3,125 shares of KalVista Pharmaceuticals, Inc.⁴
• May 21, 2026Exercised options 3,750 shares of KalVista Pharmaceuticals, Inc.⁵
• May 18, 2026Sold 1,108 shares at $26.76 of KalVista Pharmaceuticals, Inc.⁶
• May 17, 2026Exercised options 1,774 shares of KalVista Pharmaceuticals, Inc.⁶
• Feb 23, 2026Sold 4,347 shares at $15.57 of KalVista Pharmaceuticals, Inc.⁷
• Feb 22, 2026Exercised options 3,125 shares of KalVista Pharmaceuticals, Inc.⁷
• Feb 21, 2026Exercised options 3,750 shares of KalVista Pharmaceuticals, Inc.⁷
• Feb 18, 2026Sold 1,109 shares at $15.00 of KalVista Pharmaceuticals, Inc.⁸
• Feb 17, 2026Exercised options 1,774 shares of KalVista Pharmaceuticals, Inc.⁸
• Nov 24, 2025Sold 4,331 shares at $13.45 of KalVista Pharmaceuticals, Inc.⁹
• Nov 22, 2025Exercised options 3,125 shares of KalVista Pharmaceuticals, Inc.⁹
• Nov 21, 2025Exercised options 3,750 shares of KalVista Pharmaceuticals, Inc.⁹
• Nov 20, 2025Exercised options 87,390 shares of KalVista Pharmaceuticals, Inc.¹⁰
• Nov 18, 2025Sold 2,683 shares at $14.48 of KalVista Pharmaceuticals, Inc.¹¹
• Nov 17, 2025Exercised options 4,205 shares of KalVista Pharmaceuticals, Inc.¹¹
• Aug 25, 2025Sold 1,954 shares at $13.42 of KalVista Pharmaceuticals, Inc.¹²
• Aug 22, 2025Sold 2,362 shares at $13.22 of KalVista Pharmaceuticals, Inc.¹³
• Aug 22, 2025Exercised options 3,125 shares of KalVista Pharmaceuticals, Inc.¹²
• Aug 21, 2025Exercised options 3,750 shares of KalVista Pharmaceuticals, Inc.¹³
• Aug 18, 2025Sold 2,649 shares at $13.19 of KalVista Pharmaceuticals, Inc.¹⁴